1. Impact of connective tissue diseases on complications following aesthetic surgery: A matched cohort study.
- Author
-
Abbas, Fuad, Khalaf, Ryan, Reyes, Jose, Fodor, R'ay, Perozzo, Filippo, Obeid, Rommy, Al-Malak, Mazen, Jo, Diane, Husni, Elaine, Rampazzo, Antonio, and Gharb, Bahar Bassiri
- Abstract
The association between connective tissue diseases (CTDs), including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and scleroderma, and complications following aesthetic surgery is under-investigated. We hypothesized that the risk of complications following aesthetic surgery was higher in patients with these connective tissue disorders compared to matched non-CTD patients. All patients diagnosed with RA, SLE, and scleroderma who underwent aesthetic surgery at our institution from 2003–2022 were reviewed. Demographic data, comorbidities, medications, procedures, and postoperative complications were collected. Non-CTD controls were identified for each procedure and matched 1:1 based on propensity scores derived from race, sex, body mass index, smoking status, and comorbidities. Six hundred 38 patients were included, comprising 319 (50%) patients diagnosed with CTD and 319 (50%) controls. The average age at surgery was 56.3 years. There were 129 complications. There were no differences between the CTD and non-CTD patients in number of total complications (69 versus 60, p = 0.38), major complications (23 versus 16, p = 0.25), or minor complications (46 versus 44, p = 0.73). Complications were not significantly different between CTD patients and controls who underwent blepharoplasty (p = 0.38), breast reduction (p = 0.91), abdominoplasty (p = 0.46), or rhytidectomy (p = 0.50). CTD patients who underwent breast augmentation had significantly more complications than matched non-CTD patients in bivariate analysis (7 versus 0, p = 0.018 *) and multivariable logistic regression (OR: 10.2, 95% CI: 1.21 to 93.3, p = 0.039 *). Most aesthetic surgeries can safely be performed in patients with CTDs. Patients seeking breast augmentation should be counseled on a potentially increased risk of postoperative complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF